MedPath

Polyethylene glycol

Generic Name
Polyethylene glycol
Brand Names
Bi-peglyte, Clearlax, Colyte, Gavilax, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Gentlelax, Gialax, Glycolax, Golytely, Healthylax, Miralax, Moviprep, Nulytely, Peglyte, Pegylax, Plenvu, Purelax, Suflave
Drug Type
Small Molecule
CAS Number
25322-68-3
Unique Ingredient Identifier
3WJQ0SDW1A
Background

Polyethylene glycol (PEG) is a synthetic polymer produced via polymerization of ethylene oxide molecules to make joining units of ethylene glycol by an ether linkage. PEGs are water-soluble polymers that can form hydrogen bonds in a ratio of 100 water molecules per one PEG molecule. Molecular weights of PEGs vary by time of the polymerization process and the molecular weight represents the weighted average of the individual PEG molecules. PEGs differ in their physical and chemical properties depending on their molecular weight: PEGs are liquids when molecular weights are <1000 and the molecule turns to waxy solids with increasing molecular weights. The most common preparations of PEGs include PEG 3350 and PEG 400. PEGs have various applications in many fields, ranging from medical to industrial areas. PEGs have a long history of gastroenterology: PEG 3350 is a common over-the-counter osmotic laxative used to relieve occasional constipation. PEG 3350 is also used for cleansing of the colon in preparation for colonoscopy in adults.

The rationale of using PEG in gastroenterology is due to the physical properties of the compound: its potent water-binding capacity, negligible intestinal absorption with increasing molecular mass, lack of significant toxicity, and limited intestinal enzymatic degradation or bacterial metabolism all make PEG a useful therapeutic agent for the treatment of occasional constipation and bowel cleansing for preparation in colonoscopy.

Indication

Polyethylene glycol is indicated for use as an over-the-counter osmotic laxative to relieve occasional constipation. When used in combination with sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride, it is used for cleansing of the colon in preparation for colonoscopy in adults.

Associated Conditions
Chronic Constipation, Constipation, Dry Eye Syndrome (DES), Dry Eyes, Occasional Constipation
Associated Therapies
Bowel preparation therapy, Eye lubrication

A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation

Phase 2
Not yet recruiting
Conditions
Constipation - Functional
Constipation
Constipation Aggravated
Interventions
Dietary Supplement: Actazin chewable tablet
Other: Chewable Tablet
Other: Maltodextrin (Placebo)
First Posted Date
2025-02-20
Last Posted Date
2025-03-19
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
60
Registration Number
NCT06836024
Locations
🇨🇦

Hamilton Health Sciences, Hamilton, Ontario, Canada

PEG3350 Vs Senna After Urogyn Surgery

Phase 4
Not yet recruiting
Conditions
Obstructive Defecation Syndrome
Postoperative Constipation
Interventions
First Posted Date
2025-02-13
Last Posted Date
2025-02-17
Lead Sponsor
St. Joseph's Health, New York
Target Recruit Count
254
Registration Number
NCT06825260
Locations
🇺🇸

St. Joseph's Health Hospital, Syracuse, New York, United States

Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment

Recruiting
Conditions
Glaucoma
Interventions
First Posted Date
2025-02-11
Last Posted Date
2025-02-20
Lead Sponsor
Colorado Ophthalmology Associates PC
Target Recruit Count
70
Registration Number
NCT06819046
Locations
🇺🇸

Colorado Ophthalmology Associates PC, Denver, Colorado, United States

Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults

Not Applicable
Conditions
Chronic Hepatitis b
Immunotherapy
Interventions
First Posted Date
2025-01-15
Last Posted Date
2025-01-15
Lead Sponsor
Beijing Ditan Hospital
Target Recruit Count
180
Registration Number
NCT06777173
Locations
🇨🇳

Beijing Ditan hospital, Beijing, China

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

Not Applicable
Not yet recruiting
Conditions
Bowel Preparation for Colonoscopy
Interventions
First Posted Date
2024-12-11
Last Posted Date
2024-12-11
Lead Sponsor
Changhai Hospital
Target Recruit Count
1329
Registration Number
NCT06728839

CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)

Phase 1
Recruiting
Conditions
Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma
Interventions
Drug: Fecal Microbiota Transplantation
First Posted Date
2024-05-01
Last Posted Date
2025-01-23
Lead Sponsor
John Lenehan
Target Recruit Count
20
Registration Number
NCT06393400
Locations
🇨🇦

Verspeeten Family Cancer Centre (formerly known as the London Regional Cancer Program) London Health Sciences Centre, London, Ontario, Canada

Comparative Study on the Efficacy of Vibrabot Capsule and Polyethylene Glycol for Chronic Functional Constipation

Not Applicable
Recruiting
Conditions
Chronic Functional Constipation
Interventions
Device: Vibrabot capsule
First Posted Date
2024-04-15
Last Posted Date
2024-04-15
Lead Sponsor
Beijing Tsinghua Chang Gung Hospital
Target Recruit Count
45
Registration Number
NCT06364111
Locations
🇨🇳

XuanJiang, Beijing, Beijing, China

Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

Phase 4
Recruiting
Conditions
Constipation
Surgical Procedure, Unspecified
Prolapse; Female
Interventions
First Posted Date
2023-12-07
Last Posted Date
2025-03-10
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
74
Registration Number
NCT06159777
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

Phase 2
Conditions
Gender Dysphoria
Interventions
First Posted Date
2023-06-09
Last Posted Date
2024-10-02
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
30
Registration Number
NCT05897086
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

First Posted Date
2023-05-08
Last Posted Date
2025-05-11
Lead Sponsor
Tanja Andrea Gruber
Target Recruit Count
90
Registration Number
NCT05848687
Locations
🇺🇸

Phoenix Children's Hospital, Phoenix, Arizona, United States

🇺🇸

Arkansas Children's Hospital, Little Rock, Arkansas, United States

🇺🇸

Children's Hospital Los Angeles, Los Angeles, California, United States

and more 22 locations
© Copyright 2025. All Rights Reserved by MedPath